Efficacy of different methods for preventing gastroesophageal bleeding in patients with liver cirrhosis: comparative analysis
https://doi.org/10.16931/1995-5464.2022-2-31-38
Abstract
Aim. To assess the clinical efficacy of preventing gastroesophageal bleeding in patients with liver cirrhosis.
Materials and methods. From 2008 to 2019, the surgical treatment of 710 patients with cirrhosis was considered. The long-term results of preventing gastroesophageal variceal rebleeding were studied in three groups of patients: portosystemic shunt placement (367 patients), total esophagogastric disconnection (62 patients), and endoscopic procedures (281 patients). Observation periods varied from 1 to 115 months.
Results. The lowest rebleeding rate of 15.5% was observed following shunt placement (χ2 = 9.728; df = 2; р = 0.008), while the highest rate of 40.9% was observed following endoscopic treatment. By the 5th year of follow-up, only 37.5% of patients showed no signs of bleeding following endoscopic procedures. The percentage of patients who did not experience true gastroesophageal variceal rebleeding amounted to 44%, 76%, and 85% following shunt placement, total esophagogastric disconnection, and endoscopic procedures, respectively (p < 0.05).
Conclusion. Irrespective of the selected procedure, all patients with cirrhosis suffer from portal rebleeding in the longterm period. However, the lowest rebleeding rate is observed following portosystemic shunt placement.
About the Authors
F. G. NazyrovUzbekistan
Feruz G. Nazyrov – Doct. of Sci. (Med.), Professor, Academician of the Uzbek Academy of Sciences, Chief Advisor to the Director
10, Kichikkhalkayuli str., Tashkent, 100115
A. V. Devyatov
Uzbekistan
Andrey V. Devyatov – Doct. of Sci. (Med.), Prof., Head of Department of Hepatobiliary Surgery and Liver Transplantation No. 2
10, Kichikkhalkayuli str., Tashkent, 100115
A. Kh. Babadjanov
Uzbekistan
Azam Kh. Babadzhanov – Doct. of Sci. (Med.), Professor, Principal Researcher, Department of Hepatobiliary Surgery and Liver Transplantation No. 2
10, Kichikkhalkayuli str., Tashkent, 100115
U. M. Makhmudov
Uzbekistan
Ulugbek M. Makhmudov – Doct. of Sci. (Med.), Senior Researcher, Department of Hepatobiliary Surgery and Liver Transplantation No. 2
10, Kichikkhalkayuli str., Tashkent, 100115
O. A. Omonov
Uzbekistan
Oibek A. Omonov – Cand. of Sci. (Med.), Resident, Department of Hepatobiliary Surgery and Liver Transplantation No. 2
10, Kichikkhalkayuli str., Tashkent, 100115
References
1. Hoyert D.L., Gregory E.C.W. Cause-of-death data from the Fetal Death File, 2015–2017. Natl. Vital. Stat. Rep. 2020; 69 (4): 1–20. PMID: 32510316.
2. World Health Data Platform /GHO /Indicators. Liver cirrhosis, age-standardized death rates (15+), per 100,000 population. 2021. https://www.who.int/data/gho/data/indicators/indicatordetails/GHO/liver-cirrhosis-age-standardized-death-rates(15-)-per-100-000-population.
3. Cremers I., Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap. Adv. Gastroenterol. 2014; 7 (5): 206–216. https://doi.org/10.1177/1756283X14538688
4. Garcia-Tsao G., Abraldes J.G., Berzigotti A., Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017; 65 (1): 310–335. https://doi.org/10/1002/hep.28906
5. Kitsenko E.A., Anisimov A.Yu., Andreev A.I. The modern state of bleeding from variceal enlarged veins of esophagus and stomach. The Bulletin of Contemporary Clinical Medicine. 2014; 7 (5): 89–98. (In Russian)
6. Kotiv B.N., Dzidzava I.I., Onnicev I.E., Khokhlov A.V., Zubarev P.N., Soldatov S.A., Shevtsov S.V., Parfenov A.O. Surgical treatment of bleeding from esophageal and gastric varices in patients with decompensated cirrhosis. Kursk Scientific and Practical Bulletin “Man and His Health”. 2018; 2: 27–33. https://doi.org/10.21626/vestnik/2018-2/04 (In Russian)
7. Biecker E. Gastrointestinal bleeding in cirrhotic patients with portal hypertension. ISRN Hepatol. 2013; 2013: 541836. https://doi.org/10.1155/2013/541836
8. Escorsell A., Pavel O., Cardenas A., Morillas R., Llop E., Villanueva C., Garcia-Pagan J., Bosch J. Esophageal balloon tamponade vs. esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial. Hepatology. 2016; 63 (6): 1957–1996. https://doi.org/10.1002/hep.28360
9. Mallet M., Rudler M., Thabut D. Variceal bleeding in cirrhotic patients. Gastroenterol. Rep. (Oxf). 2017; 5 (3): 185–192. https://doi.org/10.1093/gastro/gox024.
10. Marot A., Trépo E., Doerig C., Moreno C., Moradpour D., Deltenre P. Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding. Aliment. Pharmacol. Ther. 2015; 42 (11–12): 1250–1260. https://doi.org/10.1002/hep.28360
11. Chen P.X., Yan L.N., Wang W.T. Health-related quality of life of 256 recipients after liver transplantation. World J. Gastroenterol. 2012; 18 (36): 5114–5121. https://doi.org/10.3748/wjg.v18.i36.5114
Supplementary files
Review
For citations:
Nazyrov F.G., Devyatov A.V., Babadjanov A.Kh., Makhmudov U.M., Omonov O.A. Efficacy of different methods for preventing gastroesophageal bleeding in patients with liver cirrhosis: comparative analysis. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2022;27(2):31-38. (In Russ.) https://doi.org/10.16931/1995-5464.2022-2-31-38